3-134360352-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016201.4(AMOTL2):c.1637T>C(p.Leu546Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,614,112 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016201.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMOTL2 | NM_016201.4 | c.1637T>C | p.Leu546Pro | missense_variant | Exon 7 of 10 | ENST00000249883.10 | NP_057285.3 | |
AMOTL2 | NM_001278683.1 | c.1811T>C | p.Leu604Pro | missense_variant | Exon 7 of 10 | NP_001265612.1 | ||
AMOTL2 | NM_001363943.2 | c.1637T>C | p.Leu546Pro | missense_variant | Exon 7 of 10 | NP_001350872.1 | ||
AMOTL2 | NM_001278685.2 | c.1631T>C | p.Leu544Pro | missense_variant | Exon 7 of 10 | NP_001265614.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152220Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250426Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135402
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461774Hom.: 0 Cov.: 32 AF XY: 0.00000825 AC XY: 6AN XY: 727192
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152338Hom.: 0 Cov.: 33 AF XY: 0.0000940 AC XY: 7AN XY: 74498
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1637T>C (p.L546P) alteration is located in exon 7 (coding exon 6) of the AMOTL2 gene. This alteration results from a T to C substitution at nucleotide position 1637, causing the leucine (L) at amino acid position 546 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at